<DOC>
	<DOC>NCT00891241</DOC>
	<brief_summary>The purpose of this clinical study is to estimate the radiation dosimetry of a single dose of LMI1195 in healthy subjects and heart failure patients undergoing positron emission tomography (PET)</brief_summary>
	<brief_title>A Phase 1 Trial to Determine Dosimetry, Biodistribution and Safety of LMI 1195-101 in Healthy Subjects and Patients With Heart Failure</brief_title>
	<detailed_description />
	<mesh_term>Heart Failure</mesh_term>
	<criteria>Cohort 1 Inclusion: Healthy, age 1840 Cohort 1 Exclusion: Significant or chronic medical illness Pregnant females Smoking within one month of enrollment Use of any prescription drugs within 4 weeks prior to dosing Cohort 2 Inclusion: 3070 year old subjects with a diagnosis of NYHA Class IIIII heart failure Ejection fraction less than or equal to 35% Rest SPECT imaging within 90 days prior to enrollment Cohort 2 Exclusion: Significant or chronic medical illness Pregnant females Known history of arrhythmogenic disorder or rhythm disorder</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>August 2011</verification_date>
	<keyword>Heart Failure, PET Imaging, Implantable Cardioverter-Defibrillator, Dosimetry</keyword>
</DOC>